The CEO Roundtable on Cancer brings together the nation's top executives to reduce cancer risk, enable early diagnosis, facilitate access to treatment, and hasten the discovery of effective therapies.
Founded at the request of President George H.W. Bush, we challenge corporate leaders to do something bold and venturesome about cancer within their own corporate families and beyond.
For over two decades, the CEO Roundtable on Cancer has mobilized corporate leaders to create meaningful, lasting progress in the fight against cancer.
Do something bold and venturesome about cancer within your own corporate families.
Project Data Sphere is an independent 501(c)(3) subsidiary of CEORT operating two complementary programs: an open-access data sharing platform housing 252+ de-identified clinical trials and 250,000+ patient records (NEJM), and closed-access precompetitive research projects where pharma, academia, the FDA, and technology partners collaborate on AI-driven oncology tools.
Deep learning–powered automation of RECIST 1.1 tumor assessments—reducing ~30% inter-radiologist variability.
Learn more →A novel volumetric 3D model for quantifying total tumor burden as an alternative to traditional RECIST.
Learn more →Conversations at the intersection of oncology, data science, and innovation — hosted by the CEO Roundtable on Cancer.
Explore the latest insights on precision oncology, AI-driven research, and breakthrough therapies. Tune in to hear from leading experts shaping the future of cancer care.
Watch on YouTube →Stay updated on the latest developments from the CEO Roundtable on Cancer and its initiatives.
The CEO Roundtable on Cancer appoints Dr. Kim Rathmell and Dr. Sunil Verma to its Life Sciences Council to strengthen oncology leadership.
Project Data Sphere’s autoRECIST initiative presented preliminary results at FDA Research Grand Rounds, advancing AI-driven tumor assessment.
Whether you're a CEO, a health leader, or an organization committed to wellness—there's a place for you in the Roundtable.